Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$7.4M-125%-$2.86M+55.5%-$3.34M+69.2%-$2.93M+71.8%-$3.29M+60.8%
$4.39M-8.2%$4.15M-15.4%$4.6M-0.9%$4.68M-1.9%$4.78M-1.0%
$440.95K+48.3%$408.32K+35.3%$310.97K-3.1%$306.08K-6.6%$297.35K-15.9%
$1.42M$4.93M
$50.27K-30.6%$97.9K+47.3%$100.19K-11.2%$91.78K-39.1%$72.47K-66.4%
-$3.83M-$4.99M
$78.61K-86.4%$263.48K-54.5%$361.86K-46.0%$450.24K-41.7%$577.31K-27.9%
$38.33M+11.2%
-$1.98M-$6.75M
$1.37M$4.83M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Cumberland Pharmaceuticals generate?
Cumberland Pharmaceuticals (CPIX) generated $1.4M in operating cash flow over the trailing twelve months.
What is Cumberland Pharmaceuticals's free cash flow?
After $50.3K of capital expenditures, Cumberland Pharmaceuticals's free cash flow was $1.4M over the trailing twelve months, down 23.9% year over year.
Where does Cumberland Pharmaceuticals's cash flow data come from?
Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.